10-Q: Bunge Global SA Reports Lower Q2 2024 Earnings Amidst Market Shifts and Acquisition Preparations

Bunge Global SA's second-quarter earnings for 2024 decreased significantly compared to the previous year, primarily due to lower segment EBIT and gross margins, despite a reduction in income tax expenses.

Summary

• Bunge Global SA reported a net income attributable to Bunge of $70 million for the three months ended June 30, 2024, a decrease of $552 million compared to the same period in 2023.
• For the six months ended June 30, 2024, the net income attributable to Bunge was $314 million, a decrease of $940 million compared to the first half of 2023.
• The decrease in net income was primarily due to lower segment EBIT in the core and non-core segments, resulting from lower gross margins.
• Diluted earnings per share were $0.48 for the quarter and $2.17 for the six-month period, compared to $4.09 and $8.24 respectively in the prior year.
• Total segment EBIT decreased to $185 million for the quarter and $618 million for the six-month period, down from $912 million and $1,798 million respectively in the prior year.
• Income tax expense decreased to $30 million for the quarter and $147 million for the six-month period, compared to $198 million and $381 million respectively in the prior year, partially offsetting the lower pre-tax income.
• Working capital decreased to $7,846 million at June 30, 2024, from $8,909 million at June 30, 2023, and $8,663 million at December 31, 2023, primarily due to lower inventory and trade receivable balances.

Sentiment

Score: 4

Explanation: The sentiment is negative due to the significant decrease in earnings and EBIT, although the company is taking strategic steps to improve its position. The market may react negatively to the lower earnings but positively to the strategic moves.

Positives

• Income tax expense decreased due to lower pre-tax income, partially offset by unfavorable discrete tax adjustments.
• The Milling segment experienced a significant increase in EBIT, driven by higher gross profits in South America.
• Bunge has secured $8.0 billion in acquisition financing for the Viterra acquisition.
• Bunge increased the aggregate size of its existing commercial paper program by $1 billion to an aggregate of $2 billion.

Negatives

• Net income attributable to Bunge decreased significantly in both the second quarter and the first half of 2024 compared to the same periods in 2023.
• Diluted earnings per share decreased substantially in both the second quarter and the first half of 2024 compared to the same periods in 2023.
• Total segment EBIT decreased significantly in both the second quarter and the first half of 2024 compared to the same periods in 2023.
• The Agribusiness segment experienced a substantial decrease in EBIT due to lower gross profits.
• The Refined and Specialty Oils segment saw a decrease in EBIT due to lower margins in soybean oil refining.
• The Sugar and Bioenergy segment's EBIT decreased significantly due to less favorable results from the BP Bunge Bioenergia joint venture.
• Working capital decreased due to lower inventory and trade receivable balances.

Risks

• The company is exposed to fluctuations in agricultural commodity prices, transportation costs, foreign currency exchange rates, interest rates, and energy costs.
• Bunge faces credit and counterparty risks through commercial sales, purchases, and derivative instruments.
• The company is subject to the risk of counterparty non-performance under forward purchase and sales contracts.
• Inflationary pressures may increase labor and overhead costs, potentially affecting results of operations.
• The company is involved in various legal proceedings and claims, which could have a material adverse effect on its financial position.
• The Viterra acquisition is subject to regulatory approvals and other customary closing conditions, and may not be completed as expected.

Future Outlook

The company expects the Viterra acquisition to close in the next several months, subject to regulatory approvals and other customary closing conditions. The acquisition of CJ is expected to close in the last half of 2024, subject to customary closing conditions. The sale of BP Bunge Bioenergia is expected to close in the fourth quarter of 2024, subject to customary closing conditions. The divestment of 40% of Bunge Iberica SA is expected to close in late 2024, subject to customary closing conditions.

Management Comments

• Management believes that the condensed consolidated financial statements reflect the largest amount of tax benefit that is more likely than not to be realized.
• Management does not expect legal matters to have a material adverse effect on Bunge's financial condition, results of operations, or liquidity.
• Management believes all related party transaction values to be similar to those that would be conducted with third parties at arm's-length.

Industry Context

The report reflects the challenges faced by agribusiness companies due to fluctuating commodity prices and global market conditions. The planned acquisition of Viterra and divestitures indicate a strategic shift to optimize the company's portfolio and market position. The company's focus on sustainability is also evident in its financing agreements.

Comparison to Industry Standards

• Bunge's performance in Q2 2024 reflects a broader trend of decreased earnings in the agribusiness sector due to volatile commodity prices, similar to what has been reported by competitors such as Archer Daniels Midland (ADM) and Cargill.
• The decrease in gross margins in Bunge's processing businesses is consistent with industry-wide challenges related to supply chain disruptions and price fluctuations, as seen in reports from companies like Louis Dreyfus Company.
• Bunge's strategic moves, such as the Viterra acquisition and the divestiture of BP Bunge Bioenergia, are similar to actions taken by other major players in the industry to consolidate and optimize their operations, such as ADM's recent acquisitions in the animal nutrition space.
• The company's focus on sustainability-linked financing is in line with the growing trend of ESG integration in the agribusiness sector, as seen in the sustainability initiatives of companies like Wilmar International.
• Bunge's debt levels and liquidity management are comparable to those of its peers, with a focus on maintaining financial flexibility through various credit facilities and commercial paper programs, similar to the strategies employed by companies like Olam International.

Legal Proceedings

• Bunge is party to claims and lawsuits, primarily non-income tax and labor claims in South America, arising in the normal course of business.
• Bunge is also involved from time to time in various contract, antitrust, environmental litigation and remediation, and other litigation, claims, government investigations, and legal proceedings.

Related Party Transactions

• Bunge purchases agricultural commodity products from certain of its unconsolidated investees and other related parties.
• Bunge also sells agricultural commodity products to certain of its unconsolidated investees and other related parties.
• Bunge receives services from and provides services to its unconsolidated investees and other related parties, including tolling, port handling, administrative support, and other services.
• Bunge provides certain advance payments for future delivery of specified quantities of agricultural commodities and advances to its unconsolidated investees.

Stakeholder Impact

• Shareholders will be impacted by the decrease in earnings and diluted earnings per share.
• Employees may be affected by the strategic changes and potential restructuring.
• Customers and suppliers may experience changes in their relationships with Bunge due to the acquisitions and divestitures.
• Creditors will be impacted by the changes in debt levels and credit ratings.

Next Steps

• The company will continue to work towards closing the Viterra acquisition in the next several months.
• The company will continue to work towards closing the acquisition of CJ in the last half of 2024.
• The company will continue to work towards closing the sale of BP Bunge Bioenergia in the fourth quarter of 2024.
• The company will continue to work towards closing the divestment of 40% of Bunge Iberica SA in late 2024.

Key Dates

Keywords

Agribusiness, Refined and Specialty Oils, Milling, Sugar and Bioenergy, EBIT, Net Income, Earnings Per Share, Commodity Prices, Acquisition, Viterra, Derivatives, Working Capital, Debt, Share Repurchase, Financial Results